The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Open accessAbstract
Chronic viral infections often result in T cell exhaustion. To determine the molecular signature of exhaustion, we compared the gene-expression profiles of dysfunctional lymphocytic choriomeningitis virus (LCMV)-specific CD8(+) T cells from chronic infection to functional LCMV-specific effector and memory CD8(+) T cells generated after acute infection. These data showed that exhausted CD8(+) T cells: (1) overexpressed several inhibitory receptors, including PD-1, (2) had major changes in T cell receptor and cytokine signaling pathways, (3) displayed altered expression of genes involved in chemotaxis, adhesion, and migration, (4) expressed a distinct set of transcription factors, and (5) had profound metabolic and bioenergetic deficiencies. T cell exhaustion was progressive, and gene-expression profiling indicated that T cell exhaustion and anergy were distinct processes. Thus, functional exhaustion is probably due to both active suppression and passive defects in signaling and metabolism. These results provide a framework for designing rational immunotherapies during chronic infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T cells acquiring multiple inhibitory surface molecules in persistent disease settings such as chronic infection [37,38] and malignancies [30,**39,40], which effectively prevent T cell activation.”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [37]
In the citing paper
“Secretion of TNF-α in some populations of cells is reduced because of the contemporary arrest of p38-MAPK and PD-1 pathways.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“However, the telomerase activity in CD8+/CD45RA+ T cells is improved by blocking only the p38 pathway but not the PD-1 signaling, indicating that non-overlapping signaling pathways are involved (193, 194).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“In these cells that present characteristics of immune senescence (decreased proliferation, lower telomerase activity, and increased presence of DNA damage), the simultaneous blockade of both p38-MAPK and PD-1 signaling supports their proliferation, both in young and in older human beings.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationPD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Self-citationGreenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationCTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Self-citationWherry, E. J., Blattman, J. N., Murali‐Krishna, K., der Most, R. G. V., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,645
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,641
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,007
Muthumani, K., Shedlock, D. J., Choo, D. K., Fagone, P., Kawalekar, O. U., Goodman, J., Bian, C. B., Ramanathan, A. A., Atman, P., Tebas, P., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100594 · Cited by 40
The Interplay between T Cells and Cancer: The Basis of Immunotherapy
Chen, C., Liu, X., Chang, C., Wang, H. Y., & Wang, R. (2023) · Genes · doi:10.3390/genes14051008 · Cited by 42
Targeting PGLYRP1 promotes antitumor immunity while inhibiting autoimmune neuroinflammation
Schnell, A., Huang, L., Regan, B. M. L., Singh, V., Vonficht, D., Bollhagen, A., Wang, M., Hou, Y., Bod, L., Sobel, R. A., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01645-4 · Cited by 39
Miguel, R. D. V., Cherpes, T. L., Watson, L. J., & McKenna, K. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903411 · Cited by 39
Therapeutic vaccination and novel strategies to treat chronic HBV infection
Bertoletti, A., & Gehring, A. J. (2009) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.09.48 · Cited by 39
Prevailing over T cell exhaustion: New developments in the immunotherapy of pancreatic cancer
Bauer, C. A., Kühnemuth, B., Duewell, P., Ormanns, S., Gress, T. M., & Schnurr, M. M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.057 · Cited by 41
Regulation of mTOR, Metabolic Fitness, and Effector Functions by Cytokines in Natural Killer Cells
Viel, S., Besson, L., Marotel, M., Walzer, T., & Marçais, A. (2017) · Cancers · doi:10.3390/cancers9100132 · Cited by 38
Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease
Zheng, X., O’Connell, C. M., Zhong, W., Nagarajan, U. M., Tripathy, M. K., Lee, D., Russell, A. N., Wiesenfeld, H. C., Hillier, S. L., & Darville, T. L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701658 · Cited by 42
Effector CD4 T cells with progenitor potential mediate chronic intestinal inflammation
Shin, B., Kress, R. L., Kramer, P. A., Darley-Usmar, V. M., Bellis, S. L., & Harrington, L. E. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172335 · Cited by 39
Roles, function and relevance of LAG3 in HIV infection
Graydon, C. G., Balasko, A. L., & Fowke, K. R. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007429 · Cited by 39
Belkina, A. C., Starchenko, A., Drake, K., Proctor, E. A., Pihl, R. M. F., Olson, A., Lauffenburger, D. A., Lin, N., & Snyder-Cappione, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02783 · Cited by 39
Kawashima, A., Kanazawa, T., Kidani, Y., Yoshida, T., Hirata, M., Nishida, K., Nojima, S., Yamamoto, Y., Kato, T., Hatano, K., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63060-1 · Cited by 41
de Moura, R. G., Covre, L. P., Fantecelle, C. H., Gajardo, V. A. T., Cunha, C. B., Stringari, L. L., Belew, A. T., Daniel, C. B., von Zeidler, S. V., Tadokoro, C. E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.632667 · Cited by 39
Kim, Y., Park, S.-J., & Broxmeyer, H. E. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002650 · Cited by 40
T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases
McKinney, E. F., & Smith, K. G. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.81 · Cited by 36
Krüppel-like factor 4 regulates the cytolytic effector function of exhausted CD8 T cells
Nah, J., & Seong, R. H. (2022) · Science Advances · doi:10.1126/sciadv.adc9346 · Cited by 40
Li, Y., Han, M., Wei, H., Huang, W., Chen, Z., Zhang, T., Qian, M., Lin, J., Nan, G., Sun, X., et al. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01118-6 · Cited by 39
A Ceramide Analogue Stimulates Dendritic Cells To Promote T Cell Responses upon Virus Infections
Pritzl, C. J., Seo, Y., Xia, C., Vijayan, M., Stokes, Z. D., & Hahm, B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402672 · Cited by 38
Phares, T. W., Stohlman, S. A., Hinton, D. R., Atkinson, R., & Bergmann, C. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001984 · Cited by 38
Boettler, T., Choi, Y. S., Salek‐Ardakani, S., Cheng, Y., Moeckel, F., Croft, M., Crotty, S., & von Herrath, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300013 · Cited by 38
Boldajipour, B. A., Nelson, A., & Krummel, M. F. (2016) · JCI Insight · doi:10.1172/jci.insight.89289 · Cited by 37
Barathan, M., Mohamed, R., Yong, Y. K., Kannan, M., Vadivelu, J., Saeidi, A., Larsson, M., & Shankar, E. M. (2018) · Cells · doi:10.3390/cells7100165 · Cited by 37
Liu, J., Cho, Y. B., Hong, H. K., Wu, S., Ebert, P. J., Bray, S. M., Wong, S. S., Ting, J. C., Calley, J. N., Whittington, C. F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67842-5 · Cited by 38
Transcriptional and epigenetic regulation of PD-1 expression
Chi, Z., Lü, Y., Yang, Y., Li, B., & Lu, P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03737-y · Cited by 38
T-cell Exhaustion in Organ Transplantation
Angeletti, A., Cantarelli, C., Riella, L. V., Fribourg, M., & Cravedi, P. (2021) · Transplantation · doi:10.1097/tp.0000000000003851 · Cited by 39
Fischer, D. S., Ansari, M., Wagner, K. I., Jarosch, S., Huang, Y., Mayr, C. H., Strunz, M., Lang, N. J., D’Ippolito, E., Hammel, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24730-4 · Cited by 41
Metabolic Implications of Immune Checkpoint Proteins in Cancer
Stirling, E. R., Bronson, S. M., Mackert, J. D., Cook, K. L., Triozzi, P. L., & Soto‐Pantoja, D. R. (2022) · Cells · doi:10.3390/cells11010179 · Cited by 39
Viral inhibitors of NKG2D ligands: Friends or foes of immune surveillance?
Jonjić, S., Polić, B., & Krmpotić, A. (2008) · European Journal of Immunology · doi:10.1002/eji.200838823 · Cited by 38
Alter, G., Rihn, S. J., Streeck, H., Teigen, N. C., Trocha, A. K., Moss, K., Cohen, K. W., Meier, A., Pereyra, F., Walker, B. D., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00341-08 · Cited by 38
T-cell senescence: A crucial player in autoimmune diseases
Lu, Y., Ruan, Y., Pan, H., Rui, K., Liu, Q., Wang, S., & Cui, D. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109202 · Cited by 41
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer
Aghbash, P. S., Hemmat, N., Baradaran, B., Mokhtarzadeh, A., Poortahmasebi, V., Oskouee, M. A., & Baghi, H. B. (2022) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.026776 · Cited by 39
Jie, C., Li, R., Cheng, Y., Wang, Z., Wu, Q., & Xie, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1122352 · Cited by 37
Advances in LAG3 cancer immunotherapeutics
Adam, K. R., Butler, S. C., Workman, C. J., & Vignali, D. A. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.10.009 · Cited by 37
Nandakumar, S., Kannanganat, S., Posey, J. E., Amara, R. R., & Sable, S. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113951 · Cited by 37
Ochel, A., Cebula, M., Riehn, M., Hillebrand, U., Lipps, C., Schirmbeck, R., Häuser, H., & Wirth, D. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.80 · Cited by 37
Roberts, E. R., Carnathan, D. G., Li, H., Shaw, G. M., Silvestri, G., & Betts, M. R. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006135 · Cited by 37
Targeting the programmed cell death-1 pathway in rheumatoid arthritis
Sandigursky, S., Silverman, G. J., & Mor, A. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.025 · Cited by 38
T lymphocytes against solid malignancies: winning ways to defeat tumours
Caruana, I., Simula, L., Locatelli, F., & Campello, S. (2018) · Cell Stress · doi:10.15698/cst2018.07.148 · Cited by 37
Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
Wijewarnasuriya, D., Bebernitz, C., Lopez, A. V., Rafiq, S., & Brentjens, R. J. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0908 · Cited by 38
Interrogating Adaptive Immunity Using LCMV
Dangi, T., Chung, Y. R., Palacio, N. M., & Penaloza‐MacMaster, P. (2020) · Current Protocols in Immunology · doi:10.1002/cpim.99 · Cited by 34
Edwards, E. S. J., Bosco, J. J., Ojaimi, S., O’Hehir, R. E., & van Zelm, M. C. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00520-8 · Cited by 38
CD38 in Advanced Prostate Cancers
Guo, C. W., Crespo, M., Gürel, B., Dolling, D. I., Rekowski, J., Sharp, A., Petremolo, A., Sumanasuriya, S., Rodrigues, D. N., Ferreira, A., et al. (2021) · European Urology · doi:10.1016/j.eururo.2021.01.017 · Cited by 36
Harnessing the IL-21-BATF Pathway in the CD8+ T Cell Anti-Tumor Response
Topchyan, P., Xin, G., Chen, Y., Zheng, S., Burns, R., Shen, J., Kasmani, M. Y., Kudek, M. R., Yang, N., & Cui, W. (2021) · Cancers · doi:10.3390/cancers13061263 · Cited by 39
Asymmetric cell division shapes naive and virtual memory T-cell immunity during ageing
Borsa, M., Barandun, N., Gräbnitz, F., Barnstorf, I., Baumann, N. S., Pallmer, K., Baumann, S., Stark, D., Baláž, M., Oetiker, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22954-y · Cited by 37
Cellular Senescence in Immunity against Infections
Marrella, V., Facoetti, A., & Cassani, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911845 · Cited by 38
Signature Channels of Excitability no More: L-Type Channels in Immune Cells
Davenport, B., Li, Y., Heizer, J. W., Schmitz, C., & Perraud, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00375 · Cited by 37
Molecular Analysis of Tumor-Promoting CD8+ T Cells in Two-Stage Cutaneous Chemical Carcinogenesis
Kwong, B. Y., Roberts, S. J., Silberzahn, T., Filler, R. B., Neustadter, J. H., Galan, A., Reddy, S., Lin, W. M., Ellis, P. D., Langford, C. F., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.362 · Cited by 37
T Cell Memory in the Context of Persistent Herpes Viral Infections
Torti, N., & Oxenius, A. (2012) · Viruses · doi:10.3390/v4071116 · Cited by 38
Rajasekaran, N., Wang, X., Ravindranathan, S., Chin, D. J., Tseng, S.-Y., Klakamp, S. L., Widmann, K., Kapoor, V. N., Vexler, V. S., Keegan, P., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03635-3 · Cited by 37
High-Avidity T Cells Are Preferentially Tolerized in the Tumor Microenvironment
Zhu, Z., Singh, V., Watkins, S. K., Bronte, V., Shoe, J. L., Feigenbaum, L., & Hurwitz, A. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1123 · Cited by 37
RetractedHIV-associated memory B cell perturbations
Hu, Z., Luo, Z., Wan, Z., Wu, H., Li, W., Zhang, T., & Jiang, W. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.008 · Cited by 36
Targeting lymphocyte co-stimulation: From bench to bedside
Felix, N. J., Suri, A., Salter–Cid, L., Nadler, S. G., Gujrathi, S., Corbo, M., & Aranda, R. (2010) · Autoimmunity · doi:10.3109/08916931003674741 · Cited by 36
Jeon, S., Leger, A. J. S., Cherpes, T. L., Sheridan, B. S., & Hendricks, R. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300582 · Cited by 36
TGF-β receptor maintains CD4 T helper cell identity during chronic viral infections
Lewis, G. M., Wehrens, E. J., Labarta-Bajo, L., Streeck, H., & Zúñiga, E. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87041 · Cited by 38
Mukherjee, S., Sengupta, R., Mukhopadhyay, D., Braun, C., Mitra, S., Roy, S., Das, N. K., Chatterjee, U., von Stebut, E., & Chatterjee, M. (2019) · Scientific Reports · doi:10.1038/s41598-018-37144-y · Cited by 36
Cho, E. J., Kim, M., Jo, D., Kim, J., Oh, J., Chung, H. C., Lee, S.-H., Kim, D., Chun, S., Kim, J., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02034-1 · Cited by 36
The Potential of Tissue-Resident Memory T Cells for Adoptive Immunotherapy against Cancer
Beumer‐Chuwonpad, A., Taggenbrock, R. L. R. E., Ngo, T. A., & van Gisbergen, K. P. J. M. (2021) · Cells · doi:10.3390/cells10092234 · Cited by 40
Calabrò, L., Rossi, G., Covre, A., Morra, A., & Maio, M. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01125-8 · Cited by 33
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma
Jain, S., Chalif, E. J., & Aghi, M. K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.812916 · Cited by 36
Regulatory effects of IRF4 on immune cells in the tumor microenvironment
Lu, J., Liang, T., Li, P., & Yin, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1086803 · Cited by 36
CD8 T Cells andToxoplasma gondii: A New Paradigm
Gigley, J. P., Bhadra, R., & Khan, I. A. (2011) · Journal of Parasitology Research · doi:10.1155/2011/243796 · Cited by 36
Recognition of self and altered self by T cells in autoimmunity and allergy
Yin, L., Dai, S., Clayton, G. M., Gao, W., Wang, Y., Kappler, J. W., & Marrack, P. (2013) · Protein & Cell · doi:10.1007/s13238-012-2077-7 · Cited by 36
Mohan, S. R., Clemente, M. J., Afable, M. G., Cazzolli, H., Bejanyan, N., Włodarski, M. W., Lichtin, A. E., & Maciejewski, J. (2009) · Haematologica · doi:10.3324/haematol.2009.009191 · Cited by 36
Generating long‐lived CD8+ T‐cell memory: Insights from epigenetic programs
Dogra, P., Ghoneim, H. E., Abdelsamed, H. A., & Youngblood, B. (2016) · European Journal of Immunology · doi:10.1002/eji.201545550 · Cited by 38
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era
Maio, M., Hamid, O., Larkin, J., Covre, A., Altomonte, M., Calabrò, L., Vardhana, S. A., Robert, C., Ibrahim, R. A., Anichini, A., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1657 · Cited by 35
Using CD69 PET Imaging to Monitor Immunotherapy-Induced Immune Activation
Edwards, K. J., Chang, B. H., Babazada, H., Lohith, K., Park, D. H., Farwell, M. D., & Sellmyer, M. A. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0874 · Cited by 35
Zhang, Y., Huang, C.-R., Zhang, H., Duan, Z., Liu, Q., Li, J.-F., Zong, Q., Wei, Y., Liu, F., Duan, W., et al. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1060053 · Cited by 30
The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer
Zhang, J., Lei, F., & Tan, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166128 · Cited by 39
Cheng, J., Xiao, Y., Peng, T., Zhang, Z., Qin, Y., Wang, Y., Shi, J., Yan, J., Zhao, Z., He, Z., et al. (2025) · Nature Cancer · doi:10.1038/s43018-024-00892-0 · Cited by 37
Oxidative-stress-induced telomere instability drives T cell dysfunction in cancer
Rivadeneira, D. B., Thosar, S. A., Quann, K., Gunn, W. G., Dean, V. G., Xie, B., Parise, A. M., McGovern, A. C., Spahr, K., Lontos, K., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.08.008 · Cited by 37
Contracting the ‘mus cells’– does down‐sizing suit us for diving into the memory pool?
Kurtuluş, S., Tripathi, P., Opferman, J. T., & Hildeman, D. A. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00920.x · Cited by 35
Snyder, C. M. (2011) · Immunologic Research · doi:10.1007/s12026-011-8251-9 · Cited by 35
CD4 T Cell Responses in Latent and Chronic Viral Infections
Walton, S. M., Mandarić, S., & Oxenius, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00105 · Cited by 35
Lassiter, B. P., Guo, S., & Beebe, S. J. (2018) · Cancers · doi:10.3390/cancers10030069 · Cited by 36
Roy, S., Coulon, P.-G. A., Srivastava, R., Vahed, H., Kim, G. J., Walia, S. S., Yamada, T., Fouladi, M. A., Ly, V. T., & BenMohamed, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02922 · Cited by 35
T Cells Play a Causal Role in Diastolic Dysfunction during Uremic Cardiomyopathy
Winterberg, P. D., Robertson, J. M., Kelleman, M. S., George, R. P., & Ford, M. L. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017101138 · Cited by 36
Burrack, A. L., Rollins, M. R., Spartz, E. J., Mesojednik, T. D., Schmiechen, Z. C., Raynor, J. F., Wang, I., Kedl, R. M., & Stromnes, I. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000765 · Cited by 33
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
Chandrasekaran, S., Funk, C. R., Kleber, T. J., Paulos, C. M., Shanmugam, M., & Waller, E. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.718621 · Cited by 36
Inclusion body myositis and associated diseases: an argument for shared immune pathologies
Nelke, C., Kleefeld, F., Preuße, C., Ruck, T., & Stenzel, W. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01389-6 · Cited by 38
Wells, A. C., Hioki, K. A., Angelou, C. C., Lynch, A. C., Liang, X., Ryan, D. J., Thesmar, I., Zhanybekova, S., Žuklys, S., Ullom, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40959-7 · Cited by 35
Zhang, Z., Xu, X., Lu, J., Zhang, S., Gu, L., Fu, J., Jin, L., Li, H., Zhao, M., Zhang, J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir165 · Cited by 35
VanBenschoten, H. M., & Woodrow, K. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113956 · Cited by 34
Maya, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511937 · Cited by 35
Effect of peptide pools on effector functions of antigen-specific CD8+ T cells
Suneetha, P. V., Schlaphoff, V., Chun, W., Stegmann, K. A., Fytili, P., Sarin, S. K., Manns, M. P., Cornberg, M., & Wedemeyer, H. H. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.11.020 · Cited by 34
Memory CD8 T cell transcriptional plasticity
Youngblood, B., Hale, J., & Ahmed, R. (2015) · F1000Prime Reports · doi:10.12703/p7-38 · Cited by 30
Self-citationXu, H., Wang, X., Lackner, A. A., & Veazey, R. S. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112580 · Cited by 34
Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance
Doedens, A. L., Rubinstein, M. P., Gross, E. T. E., Best, J. A., Craig, D., Baker, M. K., Cole, D. J., Bui, J. D., & Goldrath, A. W. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0178 · Cited by 37
DDX3 in HIV-1 infection and sensing: A paradox
Stunnenberg, M., Geijtenbeek, T. B. H., & Gringhuis, S. I. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.03.001 · Cited by 34
Angel, C. J. L., Pham, E. A., Du, H., Vallania, F., Fram, B. J., Pérez, K., Nguyen, T., Rosenberg‐Hasson, Y., Ahmed, A., Dekker, C. L., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022928118 · Cited by 35
Brauneck, F., Haag, F., Woost, R., Wildner, N. H., Tolosa, E., Rissiek, A., Vohwinkel, G., Wellbrock, J., Bokemeyer, C., Wiesch, J. S. Z., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1930391 · Cited by 34
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
Lee, J. S., Scandiuzzi, L., Ray, A., Wei, J., Hofmeyer, K. A., Abadi, Y. M., Loke, P., Lin, J., Yuan, J. D., SERREZE, D. V., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201241 · Cited by 34
Conrad, J. A., Ramalingam, R. K., Smith, R. M., Barnett, L. D., Lorey, S. L., Wei, J., Simons, B. C., Sadagopal, S., Meyer‐Olson, D., & Kalams, S. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004234 · Cited by 33
CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies
Smith, C. J., Quinn, M. A., & Snyder, C. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00352 · Cited by 37
Effects of PD-1 Signaling on Immunometabolic Reprogramming
Boussiotis, V. A., & Patsoukis, N. (2022) · Immunometabolism · doi:10.20900/immunometab20220007 · Cited by 37
Hao, J., Li, R., Zhao, X., Liu, X., Chen, X., Xie, T., Li, X., Yao, C., Sun, Q., Wei, K., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114301 · Cited by 35
Eberlein, J., Davenport, B., Nguyen, T. T., Victorino, F., Sparwasser, T. D., & Homann, D. (2011) · Journal of Virology · doi:10.1128/jvi.05949-11 · Cited by 33
HBV-Specific Adaptive Immunity
Bertoletti, A., Tan, A. T., & Gehring, A. J. (2009) · Viruses · doi:10.3390/v1020091 · Cited by 34
Immune-surveillance through exhausted effector T-cells
Zehn, D., Utzschneider, D. T., & Thimme, R. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.01.002 · Cited by 33
Schreiner, J., Thommen, D. S., Herzig, P., Bacac, M., Klein, C., Roller, A., Belousov, A., Levitsky, V., Savic, S., Moersig, W., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1062969 · Cited by 33
Franzese, O., Palermo, B., Donna, C. D., Sperduti, I., Ferraresi, V., Stabile, H., Gismondi, A., Santoni, A., & Nisticò, P. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1114203 · Cited by 33
Metadata
- Authors
- Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R.
- Affiliations
- Emory University (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Wherry, E. John
- Ahmed, Rafi
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 27
- Issue
- 4
- Pages
- 670-684
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2040353461
- Cited by
- 2,103
- References
- 56
- Citations by year
- 2026: 110 · 2025: 148 · 2024: 140 · 2023: 144 · 2022: 139 · 2021: 180 · 2020: 161 · 2019: 138 · 2018: 119 · 2017: 102 · 2016: 112 · 2015: 116 · 2014: 88 · 2013: 83 · 2012: 80
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-11-26)
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2116 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI071309, AI 30048, R01AI071309)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- CD8+ T cell exhaustion, chronic viral infection, lymphocytic choriomeningitis virus, PD-1, inhibitory receptors, T cell receptor signaling, cytokine signaling, T cell metabolism, bioenergetics, T cell migration, transcription factors, T cell anergy, gene expression profiling, immunotherapy
- MeSH terms
- Animals, Cell Differentiation, Chronic Disease, Female, Flow Cytometry, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Molecular Sequence Data, Phenotype, Virus Diseases, Gene Expression, Clonal Anergy, CD8-Positive T-Lymphocytes, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review